Search results for "Interphex"
Article
A Q&A on Bioprocessing Trends and Technologies at INTERPHEX 2016
What developments with single-use systems were discussed?
There were several storylines about single-use systems at INTERPHEX. A number of equipment manufacturers announced new bioreactors, fermen…
Resource
Interphex
April 17-19: INTERPHEX is pharmaceutical, biotechnology, and medical device development and manufacturing event where you can “Experience Science through Commercialization”.
Article
Biopharma Says It Has an Evolution in New Technologies and Processes
…ernational panel discussion on the outlook for continuous manufacturing for biologic-based drugs at Interphex was attended by a standing-room only audience, indicating strong interest in the topic. T…
Article
Tools and Processes for Mature and Emerging Therapies
In April 2019, at the INTERPHEX trade show in New York City, vendors of bioprocessing equipment and materials announced improvements to existing platforms, added options for upstream and downstream sy…
Article
Getting a Handle on Biopharma’s Most Critical Quality Attributes and Quality Control
Michalle Adkins, director of life sciences consulting at Emerson Process Management, discussed the group’s progress at INTERPHEX on April 2, 2019 (3).
As she noted, biopharmaceutical manufacturers…
Article
Speed and Flexibility Are Dual Goals for Biopharma Operations
In addition, the single-use technologies facilitate easy tech transfer between sites, company representatives said in an interview at INTERPHEX.
What new technologies and products are impacting bi…
Article
Q&A with Industry Leaders: Rita Peters
This trend continued at Interphex 2014 with the introduction of equipment and systems targeting biologics manufacturing.
In other developments, mergers, acquisitions, and supplier consolidation co…
Article
Monitoring and Control of Inline Dilution Processes
YMC has partnered with MilliporeSigma to offer a buffer delivery platform launched at INTERPHEX 2019. The integrated solution consists of a buffer dilution system, buffer concentrates, single-us…
Article
Unifying Continuous Biomanufacturing Operations
Currently, approximately 20 FDA-approved biologic products are made using perfusion, according to a comment during INTERPHEX 2017 from Parrish Galliher, chief technology officer, upstream, at Cytiva. …
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
Despite the advent of regulations and technical capabilities, market leaders at Interphex 2016 expressed their confidence to Process Development Forum that continuous processing, ripe with innovation,…